Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor
- PMID: 6155232
- PMCID: PMC1538133
Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor
Abstract
Natural killer (NK) cell activity, antibody-dependent cytotoxicity (ADCC) and the effect of interferon on NK activity was investigated in multiple sclerosis (MS) patients. NK activity measured against K-562 tumour cell line was found to be significantly low in MS patients, and this was most pronounced in the group of male patients with definitive disease. The response of NK cells to interferon proved to be impaired and almost no activation could be demonstrated in response to polyinosinic-polycytidylic acid (poly I:C). Preliminary data obtained by the determination of interferon production in several definitive MS cases reflect a defect in the interferon producing capacity of lymphocytes. The possible involvement of impaired NK cell function in the aetiopathogenesis of MS is discussed.
Similar articles
-
Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis.J Immunol. 1981 Apr;126(4):1274-8. J Immunol. 1981. PMID: 6162885
-
[Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(2):211-5. Zh Nevropatol Psikhiatr Im S S Korsakova. 1987. PMID: 2437743 Russian.
-
Natural killer cell function in trisomy-21 (Down's syndrome).Clin Exp Immunol. 1982 Mar;47(3):735-41. Clin Exp Immunol. 1982. PMID: 6177458 Free PMC article.
-
Interferon and natural killer (NK) cells.Tex Rep Biol Med. 1981-1982;41:590-5. Tex Rep Biol Med. 1981. PMID: 6189224 Review. No abstract available.
-
[The impairments of natural killer cell activity and interferon response in advanced malignant disease].Srp Arh Celok Lek. 1994 Jan-Feb;122(1-2):48-50. Srp Arh Celok Lek. 1994. PMID: 17972805 Review. Serbian.
Cited by
-
Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.Front Immunol. 2020 Apr 24;11:714. doi: 10.3389/fimmu.2020.00714. eCollection 2020. Front Immunol. 2020. PMID: 32391016 Free PMC article.
-
Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.Heart. 1996 Jun;75(6):596-601. doi: 10.1136/hrt.75.6.596. Heart. 1996. PMID: 8697164 Free PMC article. Clinical Trial.
-
Natural killer cells and their receptors in multiple sclerosis.Brain. 2013 Sep;136(Pt 9):2657-76. doi: 10.1093/brain/aws159. Epub 2012 Jun 25. Brain. 2013. PMID: 22734127 Free PMC article. Review.
-
Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis.Biomedicines. 2019 Mar 11;7(1):18. doi: 10.3390/biomedicines7010018. Biomedicines. 2019. PMID: 30862055 Free PMC article. Review.
-
Lack of correlation between impaired interferon production and natural killer activity of lymphocytes in multiple sclerosis.Arch Virol. 1982;71(3):259-65. doi: 10.1007/BF01314877. Arch Virol. 1982. PMID: 6179500
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical